z-logo
open-access-imgOpen Access
CLINICAL AND EPIDEMIOLOGICAL FEATURES OF INTRACRANIAL COMPLICATIONS OF INFLAMMATORY DISEASES OF THE ENT ORGANS IN CONDITIONS OF THE EAST-SIBERIAN REGION OF RUSSIAN FEDERATION
Author(s) -
Yu. K. Yanov,
А. А. Кривопалов,
В. А. Шаталов,
A. Yu. Shcherbuk,
С. Г. Вахрушев,
N. A. Tuzikov,
Sh. D. Iskhakov,
Andrey Gryaznov
Publication year - 2016
Publication title -
vestnik hirurgii im. i.i. grekova/vestnik hirurgii imeni i.i. grekova
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.136
H-Index - 7
eISSN - 2686-7370
pISSN - 0042-4625
DOI - 10.24884/0042-4625-2016-175-1-18-25
Subject(s) - russian federation , medicine , epidemiology , meningitis , brain abscess , mortality rate , abscess , surgery , radiology , pathology , geography , regional science
The authors investigated the epidemiological and clinical features of otogenic and rhinosinusogenic intracranial complications in East-Siberian region of Russian Federation. The rate of intracranial complications consisted of 0,2±0,1% in patients of ENT hospitals in Sakha- Yakutia, Krasnoyarsk Territory, Irkutsk Region, Republic of Tuva. The intracranial inflammatory pathology of otogenic nature was diagnosed two times more frequent than rhinosinusogenic. Meningitis was revealed at the same rate as lesions of brain substance (encephalitis, epi- and subdural abscesses). The high clinical efficacy was shown in surgical treatment of purulent polysinusitis using W. Messerklinger method of functional endoscopic rhinosinusosurgery (FESS). The method of transtemporal incision and drainage of otogenic abscess of the brain temporal lobe has a number of essential defects, because of them, the indications for application of this method should be considered and specified. It is necessary to have an interdisciplinary approach and use the modern achievements of medical science in order to develop the efficacy of treatment of given category of patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here